Cal Krzysztof, Mikolaszek Barbara, Hess Tobias, Papaioannou Markos, Lenik Joanna, Ciosek-Skibińska Patrycja, Wall Helene, Paszkowska Jadwiga, Romanova Svitlana, Garbacz Grzegorz, Zakowiecki Daniel
Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Gdansk, al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.
Chemische Fabrik Budenheim KG, Rheinstrasse 27, 55257 Budenheim, Germany.
Pharmaceuticals (Basel). 2023 Feb 6;16(2):242. doi: 10.3390/ph16020242.
Sprinkle formulations represent an interesting concept of medicinal products aimed at the steadily growing population of patients suffering from swallowing difficulties (dysphagia). In the present work, immediate-release sprinkle MUPS (multiple-unit pellet system) containing rosuvastatin calcium as a model drug substance was successfully developed. The formulation was prepared by drug layering technique using novel calcium phosphate-based starting pellets (PharSQ Spheres CM) of three different particle sizes. The study showed that the developed multiparticulates were characterized by uniform distribution of coating layers thickness, as well as fast dissolution rate (more than 85% of rosuvastatin calcium dissolved within 30 min, as required by the relevant USP/NF monograph). Rosuvastatin calcium, like other statins, has a bitter, unpleasant taste. Investigations conducted with an electronic tongue suggested that the developed formulation achieved the desired taste-masking efficiency. The effect was found to be particle size-dependent, improving as the size of the multiparticulates increased.
撒剂剂型代表了一种针对吞咽困难(吞咽障碍)患者群体不断增长的药品有趣概念。在本研究中,成功开发了以瑞舒伐他汀钙为模型药物的速释撒剂多单元微丸系统(MUPS)。该制剂采用药物层积技术,使用三种不同粒径的新型磷酸钙基起始微丸(PharSQ Spheres CM)制备而成。研究表明,所开发的多颗粒制剂具有包衣层厚度均匀分布以及快速溶解速率的特点(根据相关美国药典/国家处方集专论要求,30分钟内超过85%的瑞舒伐他汀钙溶解)。瑞舒伐他汀钙与其他他汀类药物一样,具有苦味且味道不佳。使用电子舌进行的研究表明,所开发的制剂达到了预期的掩味效果。发现该效果与粒径有关,随着多颗粒尺寸的增加而改善。